热门资讯> 正文
Sutro Biopharma falls as it announces 1-for-10 reverse stock split
2025-12-01 21:16
- Sutro Biopharma (STRO) said on Monday that its board has approved a reverse stock split of the company's outstanding shares of common stock at a ratio of 1-for-10.
- Sutro’s common stock will begin trading on a post-reverse stock split basis on December 3, 2025, under the company's existing trading symbol “STRO.”
- The reverse stock split is intended to regain compliance with Nasdaq’s minimum bid price requirement of $1.00 per share.
- The reverse stock split reduces the number of shares of the company's outstanding common stock from approximately 85.19M shares to approximately 8.52M.
- Sutro Biopharma (STRO) shares were down more than 12% in premarket trading.
More on Sutro Biopharma
- Sutro Biopharma, Inc. (STRO) Discusses Strategic Reset and Progress in Next-Generation ADC Pipeline and Platform Innovation - Slideshow
- Sutro Biopharma, Inc. (STRO) Discusses Strategic Reset and Progress in Next-Generation ADC Pipeline and Platform Innovation Transcript
- Sutro Biopharma announces restructuring to extend cash runway
- Seeking Alpha’s Quant Rating on Sutro Biopharma
- Historical earnings data for Sutro Biopharma
推荐文章
美股机会日报 | 止跌企稳！纳指期货盘前涨约0.5%，有分析称美股连遭重挫后或回升；亚马逊盘前大跌超8%
一周财经日历 | 事关降息！美国1月非农、CPI数据下周公布；恒指季检结果下周五揭晓
华尔街大多头漫谈黄金“黑天鹅”风险：马斯克实现太空采金，化身全球央行行长
避险情绪席卷市场 华尔街青睐的热门交易纷纷崩跌
华盛早报 | 无一幸免！美股、金银、加密货币与原油集体崩盘；南向资金爆买250亿港元！创约半年来新高；千问APP今日启动30亿免单
亚马逊股价盘后大跌近10%，巨额资本支出引发担忧
比特币暴跌带来124亿美元巨亏 Saylor的金融实验岌岌可危
2月6日外盘头条：比特币暴跌 亚马逊预计今年资本支出将达2000亿美元 交易员料美联储将比预期更早降息
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
